WADA Releases 2026 Annual Report: Testing Volume Growth Slows, 45% of Non-Conformities Sit in Sample Collection

5:40 a.m. at a pool in Nha Trang. I stood beside lane four and watched a doping control officer open a plastic case of sample tubes, then set down a form and a pen. The 200m breaststroke swimmer next to me yawned, signed, and walked toward the locker room. He did not ask why he had been selected. Nobody asks. For most fans, that is the entire extent of what they know about the anti-doping system: a stranger arriving before sunrise, a piece of paper, one sample tube, and a silence that stretches for months afterward. Years later, reading the World Anti-Doping Agency's 2026 annual report, I finally saw the vast machine standing behind that silence. From one mispronounced name at a World Cup, I learned that football does not begin with the foot, but with the ear. My job works the same way: everything starts with verification, not with a headline. This report is not the technical file of any single sport. It is a cross-sport governance ledger: how many samples were collected, how many returned adverse findings, how many organizations failed audits, how much money came in and went out, and one new code that has been adopted but is not yet in force. Reading it feels closer to reading the balance sheet of a power institution than the results sheet of a tournament. The core data series runs from 2026 to 2026. Four pillars sit inside it: testing volume, the Adverse Analytical Finding (AAF) rate, the compliance record of member organizations, and the financial picture. For anyone working in swimming, this is the ground layer every athlete stands on, even though very few of them have ever read a single page of it. While the transfer market floods fans with hundreds of rumors a week, reports like this pass by almost in silence. Qatar was hot, but the transfer shock of that year was hotter than the desert wind — and precisely for that reason, people skip the structural part sitting behind it. The transfer window taught me one thing: noise is always louder than signal, until the signal comes back to bite the results. On the first pillar, global testing volume rose from 288,865 samples in 2026 to 297,965 in 2026, roughly 9,100 more. At a glance, that is positive growth. Placed next to the previous year, however, the picture changes color: 2026–2026 grew 12.5 percent, while 2026–2026 grew only 3.2 percent. This is a growth curve that is flattening — strong at the front, tapering toward the end. I placed those two figures side by side the way I still time every pressing run of a midfielder with a stopwatch: if the 12.5 percent pace had held, 2026 should have added more than 36,000 samples, roughly 325,000 in total. The actual figure was 297,965. That gap of nearly 27,000 samples is what went missing, and no line in the report names it. The second pillar is more interesting. The adverse finding rate across three years was 0.77 percent (2026), 0.80 percent (2026) and 0.78 percent (2026). All three values sit inside a 0.03 percentage point band. To anyone used to reading data, a line that flat across three seasons is a strong signal: it is stable enough to serve as a baseline rather than statistical noise. Data does not lie, but it does whisper. A rising sample count alongside a static detection rate opens two explanations, and the report does not carry enough evidence to separate them. One is that the real prevalence of prohibited substance use is stable at some level. The other is that sample selection has become more precise, targeting groups with an equivalent positivity probability instead of scattering tests broadly. Both readings are reasonable, and both lead to opposing policy conclusions. The third pillar is where the analysis should stop. Sample collection accounted for 45 percent of all non-conformities in the reports, up 11 percent year on year, with 23 percent of those graded critical. In other words, the largest hole in the global anti-doping system sits in the collection process itself — where the chain of custody can break, where timing, temperature, sealing and paperwork decide whether a sample still has value. Meanwhile, the overall audit picture looks rosier: average non-conformities fell from 25.5 to 20. But that improvement rests on just nine audits. Nine audit cases for a system spanning more than 60 countries is a thin evidentiary base — enough to note, not enough to call a trend. Finance is the darkest section. WADA fell 8.3 million USD short of budget, with the United States 3.8 million USD in arrears and Russia 3.9 million USD behind — almost exactly enough to explain the entire shortfall. At the same time, the agency still recorded a net surplus of 1.2 million USD. An organization that is simultaneously in surplus and far short of budget is usually one that has cut or deferred spending, and in a system where money mostly flows into testing capacity, deferred spending usually means fewer samples. Another direction is opening up: WADA says it is shifting focus from traditional testing toward investigations and prevention. More than 250 investigation operations, 88 laboratories dismantled, over 90 tons of materials seized. It is the kind of shift I see often in swimming: when resources are limited, you move from counting laps to optimizing each lap. At another layer, WADA and its Athlete Council ran consultations with more than 600 athletes and representatives from over 60 countries and more than 70 sports. The 2027 World Anti-Doping Code was adopted in Busan, South Korea, and takes effect on January 1, 2027. The notable point is that the headline and the data do not match. The title says testing is rising, but the interior shows a curve slowing down. Every sport is its own universe, and I am lucky to be a traveler between those orbits — but the shared orbit cannot be read from a headline. Growth of 3.2 percent is still growth; it is simply no longer last year's story. The counterintuitive angle sits here: when media and fans talk about doping, they always picture an athlete. Yet the largest block of data in the report concerns organizations. Forty-five percent of non-conformities belong to sample collection, not to anyone's body. The biggest risk to clean sport in this period may not be a positive test, but an understaffed laboratory, a collector who has not been retrained, a seal broken in transit. And when two major contributors fall behind at the same time, faith in the new code depends on a question the report does not answer: who guarantees resources for the enforcer, when the payer is part of the problem? For swimming, this question carries real weight. It is a sample-hungry sport: one athlete contests multiple events, trains through long blocks, and is subject to out-of-competition testing year-round. If testing capacity contracts in cash-poor federations, the first thing cut is usually the test nobody sees. The gap between now and January 1, 2027 also deserves watching. A code that is adopted but not yet in force creates a window in which old behavior can persist without being judged under the new standard. In sport, such transition periods tend to be when the weakest organizations suffer most and the strongest prepare earliest. I run like an athlete, jump between sports like an adrenaline addict, and after all these years I still believe what protects clean athletes is not the harshest sanction, but the regularity of a process that leaves no one out. What worries me in this year's report is that this regularity is being measured in money, and the money is late. If a system is only as strong as the resources of those who volunteer to pay, then when the biggest payer stops, who will be the one collecting samples at 5:40 a.m. at a pool nobody is watching?